Nine-year results following treatment of intrabony periodontal defects with an enamel matrix derivative: Report of 26 cases

International Journal of Periodontics and Restorative Dentistry

Volumn 27, Issue 3, 2007, Pages 221-229

  Sculean, Anton ^a   Schwarz, Frank ^b   Chiantella, Giovanni Carlo ^a,c   Miliauskaite, Asta ^d   Arweiler, Nicole Birgit ^c   Becker, Jürgen ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c Reggio Calabria ^*  (Germany)

^d SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENAMEL MATRIX PROTEINS; ENAMEL PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; HUMAN; JAW DISEASE; LONGITUDINAL STUDY; MIDDLE AGED; OSTEOLYSIS; PERIODONTICS; TREATMENT OUTCOME;

ADULT; ALVEOLAR BONE LOSS; DENTAL ENAMEL PROTEINS; HUMANS; LONGITUDINAL STUDIES; MANDIBULAR DISEASES; MAXILLARY DISEASES; MIDDLE AGED; PERIODONTAL INDEX; TREATMENT OUTCOME;

EID: 34250364986     PISSN: 01987569     EISSN: 19453388     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Hammarström L. Enamel matrix, cementum development and regeneration. J Clin Periodontol 1997;24:658-668.
2. Fong CD, Slaby I, Hammarström L. Amelin, an enamel related protein transcribed in the epithelial root sheath of rat teeth. J Bone Miner Res 1996;11:892-898.
3. Fong CD, Hammarström L. Expression of amelin and amelogenin in epithelial rooth sheath remnants of fully formed rat molars. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;90:218-223.
4. Lyngstadaas SP, Lundberg E, Ekdahl H, Andersson C, Gestrelius S. Autocrine growth factors in human periodontal ligament cells cultured on enamel matrix derivative. J Clin Periodontol 2001;28:181-188.
5. Schwartz Z, Carnes DL, Pulliam R, et al. Porcine fetal enamel matrix derivative stimulates proliferation but not differentiation of pre-osteoblastic 2T9 cells, inhibits proliferation and stimulates differentiation of osteoblast-like MG63 cells, and increases proliferation and differentiation of normal human osteoblast NHOst cells. J Periodontol 2000;71:1287-1296.
6. Van der Pauw MT, Van den Bos T, Everts V, Beertsen W. Enamel matrix-derived protein stimulates attachment of periodontal ligament fibrablast and enhances alkaline phosphatase activity and transforming growth factor β1 release of periodontal ligament and gingival fibroblasts. J Periodontol 2000;71:31-43.
7. Gestrelius S, Andersson C, Johansson AC, et al. Formulation of enamel matrix derivative for surface coating. Kinetics and cell colonization. J Clin Periodontol 1997;24:678-684.
8. Kawase T, Okuda K, Yoshie H, Burns DM. Cytostatic action of enamel matrix derivative (EMDOGAIN) on human oral squamous cell carcinoma-derived SCC25 epithelial cells. J Periodontal Res 2000;35:291-300.
9. Okubo K, Kobayashi M, Takiguchi T, et al. Participation of endogenous IGF-I and TGF-beta 1 with enamel matrix derivativestimulated cell growth in human periodontal ligament cells. J Periodontal Res 2003;38:1-9.
10. Suzuki S, Nagano T, Yamakoshi Y, et al. Enamel matrix derivative gel stimulates signal transduction of BMP and TGF-β. J Dent Res 2005;84:510-514.
11. Kawase T, Okuda K, Yoshie H, Burns DM. Anti-TGF-beta antibody blocks enamel matrix derivative-induced upregulation of p21WAF1/cip1 and prevents its inhibition of human oral epithelial cell proliferation. J Periodontal Res 2002;37:255-262.
12. Hammarström L, Heijl L, Gestrelius S. Periodontal regeneration in a buccal dehiscence model in monkeys after application of enamel matrix proteins. J Clin Periodontol 1997;24:669-677.
13. Sculean A, Donos N, Brecx M, Reich E, Karring T. Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. An experimental study in monkeys. J Clin Periodontol 2000;27:466-472.
14. Heijl L. Periodontal regeneration with enamel matrix derivative in one human experimental defect. A case report. J Clin Periodontol 1997;24:693-696.
15. Mellonig JT. Enamel matrix derivative for periodontal reconstructive surgery:Technique and clinical and histologic case report. Int J Periodontics Restorative Dent 1999;19:9-19.
16. Sculean A, Donos N, Windisch P, et al. Healing of human intrabony defects following treatment with enamel matrix proteins or guided tissue regeneration. J Periodontal Res 1999;34:310-322.
17. Yukna RA, Mellonig J. Histologic evaluation of periodontal healing in humans following regenerative therapy with enamel matrix derivativ. A 10-case series. J Periodontol 2000;71:752-759.
18. Sculean A, Chiantella GC, Windisch P, Donos N. Clinical and histologic evaluation of treatment of intrabony defects with an enamel matrix protein derivative (Emdogain). Int J Periodontics Restorative Dent 2000;20:375-381.
19. Bosshardt DD, Sculean A, Windisch P, Pietursson BE, Lang NP. Effects of enamel matrix proteins on tissue formation along the roots of human teeth. J Periodontal Res 2005;40:158-167.
20. Mazjoub Z, Bobbo M, Atiyeh F, Cordioli G. Two patterns of histologic healing in an intrabony defect following treatment with an enamel matrix derivative: A human case report. Int J Periodontics Restorative Dent 2005;25:283-294.
21. Heijl L, Heden G, Svardström G, Östgren A. Enamel matrix derivative (Emdogain) in the treatment of intrabony periodontal defects. J Clin Periodontol 1997;24:705-714.
22. Sculean A, Reich E, Chiantella G, Brecx M. Treatment of intrabony periodontal defects with an enamel matrix protein derivative (Emdogain). A report of 32 cases. Int J Periodontics Restorative Dent 1999;19:157-163.
23. Heden G, Wennström J, Lindhe J. Periodontal tissue alterations following Emdogain treatment of periodontal sites with angular bone defects. A series of case reports. J Clin Periodontol 1999;26:855-860.
24. Pontoriero R, Wennström J, Lindhe J. The use of barrier membranes and enamel matrix proteins in the treatment of angular bone defects. A prospective controlled clinical study. J Clin Periodontol 1999; 26:833-840.
25. Okuda K, Momose M, Miyazaki A, et al. Enamel matrix derivative in the treatment of human intrabony osseous defects. J Periodontol 2000;71:1821-1828.
26. Froum SJ, Weinberg MA, Rosenberg E, Tarnow D. A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: A 12-month re-entry study. J Periodontol 2001; 72:25-34.
27. Tonetti MS, Lang NP, Cortellini P, et al. Enamel matrix proteins in the regenerative therapy of deep intrabony defects. A multicenter randomized controlled clinical trial. J Clin Periodontol 2002;29:317-325.
28. Sculean A, Windisch P, Chiantella GC, Donos N, Brecx M, Reich E. Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. A prospective controlled clinical study. J Clin Periodontol 2001;28:397-403.
29. Zucchelli G, Bernardi F, Montebugnoli L, De Sanctis M. Enamel matrix proteins and guided tissue regeneration with titaniumreinforced expanded polytetrafluoroethylene membranes in the treatment of intrabony defects: A comparative controlled clinical trial. J Periodontol 2002;73:3-12.
30. Silvestri M, Sartori S, Rasperini G, Ricci G, Rota C, Cattaneo V. Comparison of intrabony defects treated with enamel matrix derivative versus guided tissue regeneration with a nonresorbable membrane. J Clin Periodontol 2003;30:386-393.
31. Wachtel H, Schenk G, Bohm S, Weng D, Zuhr O, Hurzeler MB. Microsurgical access flap and enamel matrix derivative for the treatment of periodontal intrabony defects: A controlled clinical study. J Clin Periodontol 2003;30:496-504.
32. Sanz M, Tonetti MS, Zabalegui I, et al. Treatment of intrabony defects with enamel matrix proteins or barrier membranes:Results from a multicenter practice-based clinical trial. J Periodontol 2004;75:726-733.
33. Zetterström O, Andersson C, Eriksson L, et al. Clinical safety of enamel matrix derivative (Emdogain) in the treatment of periodontal defects. J Clin Periodontol 1997; 24:697-704.
34. Sculean A, Donos N, Miliauskaite A, Arweiler N, Brecx M. Treatment of intrabony defects with enamel matrix proteins or bioresorbable membranes. A four-year follow-up split-mouth study. J Periodontol 2001;72:1695-1701.
35. Sculean A, Chiantella GC, Miliauskaite A, Brecx M, Arweiler NB. Four-year results following treatment with an enamel matrix protein derivative: A report of 46 cases. Int J Periodontics Restorative Dent 2003;23:345-351.
36. Parodi R, Santarelli GA, Gasparetto B. Treatment of intrabony defects with Emdogain: Results at 36 months. Int J Periodontics Restorative Dent 2004;24:57-63.
37. Glise JM, Blanc A, Monnet-Corti VM, Borghetti A. Results at 3 years of treatment of intrabony defects with enamel matrix proteins [in French]. J Parodontol Implantol Orale 2005;23:189-196.
38. Sculean A, Donos N, Schwarz F, Becker J, Brecx M, Arweiler NB. Five-year results following treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. J Clin Periodontol 2004; 31:545-549.
39. Francetti L, Trombelli L, Lombardo G, et al. Evaluation of efficacy of enamel matrix derivative in the treatment of intrabony defects: A 24-month multicenter study. Int J Periodontics Restorative Dent 2005;25:461-473.
40. Heden G, Wennström JL. Five-year follow-up of regenerative periodontal therapy with enamel matrix derivative at sites with angular bone defects. J Periodontol 2006;77:295-301.
41. Rasperini G, Silvestri M, Ricci G. Long-term clinical observation of treatment of infrabony defects with enamel matrix derivative (Emdogain): Surgical reentry. Int J Periodontics Restorative Dent 2005;25:121-127.
42. Löe H. The Gingival Index, the Plaque Index and the Retention Index system. J Periodontol 1967;38:610-616.
43. Tonetti MS, Pini Prato GP, Cortellini P. Effect of cigarette smoking on periodontal health following GTR in infrabony defects. A preliminary retrospective study. J Clin Periodontol 1995;22:229-234.
44. Tonetti MS, Pini Prato G, Cortellini P. Factors affecting the healing response of intrabony defects following guided tissue regeneration and access flap surgery. J Clin Periodontol 1996;23:548-556.
45. Rosling B, Nyman S, Lindhe J. The effect of systemic plaque control on bone regeneration in infrabony pockets. J Clin Periodontol 1976;3:38-53.
46. Polson AM, Heijl LC. Osseous repair in infrabony periodontal defects. J Clin Periodontol 1978;5:13-23.